# Liver Cirrhosis trials recruiting, no drug phase: 80 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 80 trials with no drug phase for Liver Cirrhosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Liver Cirrhosis trials with no drug phase: 80 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/liver-cirrhosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 80
- Recruiting or not yet: 80
- Read on: November 19, 2026

## Trials

The 25 newest of 80, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07936552 | Blood Flow Restriction Training After TIPS Placement in Liver Cirrhosis | German Diabetes Center | Not applicable | Not yet recruiting | Liver Cirrhosis, TIPS Insertion | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936552) |
| November 6, 2026 | NCT07923318 | Optimal Treatment Strategy for Spontaneous Bacterial Peritonitis | Chonnam National University Hospital | Not applicable | Recruiting | Spontaneous Bacterial Peritonitis, Paracentesis, Treatment Efficacy, Adverse Events, Survival Rate | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923318) |
| October 29, 2026 | NCT07903103 | Prickly Pear Pulp Powder Along With an Anti-inflammatory Diet in Patients Having Liver Fibrosis | University of Lahore | Not applicable | Not yet recruiting | Lipid Profile, Blood Glucose, Liver Enzymes | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903103) |
| October 28, 2026 | NCT07901556 | Effect of Mini-Program Monitoring on Hepatic Encephalopathy in Post-TIPS Patients | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Not applicable | Not yet recruiting | Hepatic Encephalopathy, Liver Cirrhosis | 394 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901556) |
| October 14, 2026 | NCT07874204 | Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Not applicable | Not yet recruiting | Liver Cirrhosis, Hepatic Encephalopathy (HE), Minimal Hepatic Encephalopathy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874204) |
| October 1, 2026 | NCT07852416 | Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Not yet recruiting | Liver Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852416) |
| September 2, 2026 | NCT07799948 | Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS | Air Force Military Medical University, China | Not applicable | Recruiting | Hepatic Encephalopathy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Portal Hypertension, Liver Cirrhosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799948) |
| August 10, 2026 | NCT07755059 | Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis | Massachusetts General Hospital | Not applicable | Not yet recruiting | Ascites, Liver Cirrhosis, Hypertension, Portal | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755059) |
| August 6, 2026 | NCT07750587 | Predicting Response and Exposure Changes in Cirrhosis for Effectiveness | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Not yet recruiting | Liver Cirrhosis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750587) |
| July 28, 2026 | NCT07730853 | Isocaloric Navy-Bean Substitution in Adults With MASLD | Icahn School of Medicine at Mount Sinai | Not applicable | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Liver Fibrosis, Metabolic Dysfunction-Associated... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730853) |
| June 9, 2026 | NCT07637539 | Elastography-based Brief Alcohol Intervention in Hospitalized Individuals | Oslo University Hospital | Not applicable | Recruiting | Alcoholic Liver Disease (ALD), Alcohol Use Disorder | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07637539) |
| May 15, 2026 | NCT07590284 | Sonazoid CEUS for Early HCC Surveillance | Tianjin Third Central Hospital | Not applicable | Not yet recruiting | Liver Cirrhosis, Liver Fibrosis | 556 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590284) |
| May 14, 2026 | NCT07587671 | Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis | West China Hospital | Not applicable | Not yet recruiting | Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices, Hepatic Encephalopathy | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587671) |
| May 1, 2026 | NCT07561138 | Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation | Sponsor not shown (see the record) | Not applicable | Recruiting | End-stage Liver Disease, Liver Cirrhosis, Liver Transplantation, Malnutrition, Sarcopenia, Frailty | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561138) |
| April 28, 2026 | NCT07553858 | Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy | Rutgers, The State University of New Jersey | Not applicable | Not yet recruiting | Hepatic Encephalopathy, Liver Cirrhosis, Portal Shunt Systemic | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553858) |
| April 22, 2026 | NCT07544121 | Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis... | Nanfang Hospital, Southern Medical University | Not applicable | Not yet recruiting | HEPATITIS B CHRONIC, Cirrhosis, Liver, Hepatocellular Carcinoma (HCC) | 1,034 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544121) |
| March 27, 2026 | NCT07495332 | Siemens Biomarker Multi-modality | Duke University | Not applicable | Recruiting | Fatty Liver, Hepatic Steatosis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495332) |
| March 25, 2026 | NCT07492862 | Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Porto-sinusoidal Vascular Liver Disorder, Liver Cirrhosis, Portal Hypertension, Noncirrhotic, Portal Hypertension... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492862) |
| March 18, 2026 | NCT07481032 | Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis... | Nanfang Hospital, Southern Medical University | Not applicable | Not yet recruiting | Cirrhosis, Liver, Hepatocellular Carcinoma (HCC), HEPATITIS B CHRONIC | 1,034 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481032) |
| March 13, 2026 | NCT07470515 | Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study | Medical University Innsbruck | Not applicable | Not yet recruiting | Liver Cirrhosis, Refractory Ascites, Variceal Bleeding, Portal Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470515) |
| March 12, 2026 | NCT07465588 | Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease | Massachusetts General Hospital | Not applicable | Not yet recruiting | Alcohol Use Disorder, Alcohol-associated Liver Disease, Liver Cirrhosis, Alcoholic, Alcohol-Associated Hepatitis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465588) |
| March 12, 2026 | NCT07465471 | Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. | Institute of Liver and Biliary Sciences, India | Not applicable | Not yet recruiting | Liver Cirrhosis | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465471) |
| February 20, 2026 | NCT07424963 | Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA) | Military University Hospital, Prague | Not applicable | Recruiting | Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07424963) |
| February 10, 2026 | NCT07400367 | Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With... | Fu Jen Catholic University Hospital | Not applicable | Recruiting | Liver Elastography, Liver Steatosis, Liver Function Test, Insulin Resistance, Cardiometabolic Risk Factors | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400367) |
| January 28, 2026 | NCT07374185 | Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis | Global Stem Cell Center, Baghdad | Not applicable | Recruiting | Liver Cirrhosis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374185) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Massachusetts General Hospital | 4 |
| Institute of Liver and Biliary Sciences, India | 4 |
| Northern Jiangsu People's Hospital | 4 |
| The Cleveland Clinic | 3 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
| RenJi Hospital | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| University Hospital, Angers | 2 |
| Air Force Military Medical University, China | 2 |
| Universitair Ziekenhuis Brussel | 2 |
| General Hospital of Shenyang Military Region | 2 |
| Medical University of Graz | 2 |
| The Second Affiliated Hospital of Chongqing Medical University | 2 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
| Hospices Civils de Lyon | 2 |
| German Diabetes Center | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Zhejiang University | 1 |
| Military University Hospital, Prague | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Medical University Innsbruck | 1 |
| Fu Jen Catholic University Hospital | 1 |
| Karolinska University Hospital | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Yaqrit Ltd | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 17 |
| United States | 11 |
| France | 6 |
| India | 6 |
| Germany | 4 |
| Austria | 3 |
| Denmark | 3 |
| Italy | 3 |
| Greece | 2 |
| Belgium | 2 |
| Spain | 2 |
| Czechia | 1 |
| Taiwan | 1 |
| Sweden | 1 |
| United Kingdom | 1 |
| Canada | 1 |
| Switzerland | 1 |
| Pakistan | 1 |
| South Korea | 1 |
| Iraq | 1 |
| Poland | 1 |
| Norway | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Preschools in the United States](https://specstream.ai/data/businesses/preschools/united-states)
- [Periodontics practices in the United States](https://specstream.ai/data/businesses/periodontics-practices/united-states)
- [Outpatient care facilities in the United States](https://specstream.ai/data/businesses/outpatient-care-facilities/united-states)
- [Nepalese restaurants in the United States](https://specstream.ai/data/businesses/nepalese-restaurants/united-states)
- [Medical service organizations in the United States](https://specstream.ai/data/businesses/medical-service-organizations/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
